Regulation of Staphylococcus aureus capsular polysaccharide type 5: CO2 inhibition in vitro and in vivo

Journal of Infectious Diseases

Volumn 176, Issue 2, 1997, Pages 431-438

  Herbert, Silvia ^b   Worlitzsch, Dieter ^b   Dassy, Bruno ^b   Boutonnier, Alain ^b   Fournier, Jean Michel ^b   Bellon, Gabriel ^b   Dalhoff, Axel ^b   Döring, Gerd ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

POLYSACCHARIDE;

ACETYLATION; ARTICLE; BACTERIAL GROWTH; CELL KILLING; CELL PROTECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GRANULOMA; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; LUNG PARENCHYMA; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0030753613     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514061     Document Type: Article

References (15)

1. Høiby N. Microbiology of cystic fibrosis. In: Hodson ME, Geddes DM, eds. Cystic fibrosis. London: Chapman and Hall, 1994:75-98.
2. Christensson B, Boutonnier A, Ryding U, Fournier JM. Diagnosing Staphylococcus aureus endocarditis by detecting antibodies against S. aureus capsular polysaccharide types 5 and 8. J Infect Dis 1990;163:530-3.
3. Arvidson S. Extracellular enzymes from Staphylococcus aureus. In: Easmon CSF, Adlam C, eds. Staphylococci and staphylococcal infections. London: Academic Press, 1983:745-808.
4. Karakawa WW, Vann WF. Capsular polysaccharides of S. aureus. Semin Infect Dis 1982;4:285-93.
5. Sompolinsky D, Samra Z, Karakawa WW, Vann WF, Schneerson R, Malik Z. Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types. J Clin Microbiol 1985;22:828-34.
6. Albus A, Fournier JM, Wolz C, et al. Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis. J Clin Microbiol 1988;26:2505-9.
7. Hochkeppel HK, Braun DG, Vischer W, et al. Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8. J Clin Microbiol 1987;25:526-30.
8. Poutrel B, Boutonnier A, Sutra L, Fournier JM. Prevalence of capsular polysaccharide types 5 and 8 among Staphylococcus aureus isolates from cow, goat, and ewe milk. J Clin Microbiol 1988;26:38-40.
9. Branger C, Fournier JM, Loulergue J, et al. Epidemiology of Staphylococcus aureus in patients with cystic fibrosis. Epidemiol Infect 1994;112:489-500.
10. Fournier JM, Vann WF, Karakawa WW. Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide. Infect Immun 1984;45:87-93.
11. Liau DF, Hash JH. Structural analysis of the surface polysaccharide of Staphylococcus aureus M. J Bacteriol 1977;131:194-200.
12. Moreau M, Richards JC, Fournier JM, Byrd RA, Karakawa WW, Vann WF. Structure of the type-5 capsular polysaccharide of Staphylococcus aureus. Carbohydr Res 1990;201:285-97.
13. Soell M, Diab M, Haan-Archipoff G, et al. Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines. Infect Immun 1995;63:1380-6.
14. Albus A, Arbeit RD, Lee JC. Virulence of Staphylococcus aureus mutants altered in type 5 capsule production. Infect Immun 1991;59:1008-14.
15. Xu S, Arbeit RD, Lee JC. Phagocytic killing of microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun 1992;60:1358-62.